Clinical trial
Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain
NCT00226395 · Endo Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00226395 |
|---|---|
| Title | Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain |
| Official title | Randomized, Double-Blind, Placebo- and Active-Control, Single- and Multiple-Dose Evaluation of the Analgesic Efficacy and Safety of Oxymorphone Immediate Release (IR) Tablets in Patients With Moderate/Severe Pain Following Abdominal Surgery |
| Lead sponsor | Endo Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Pain |
| Intervention type | Drug |
| Interventions | Oxymorphone immediate release |
| Enrollment | 320 |
| Start date | Sep 1, 2004 |
| Completion | Aug 1, 2005 |
| First posted | Sep 27, 2005 |
| Last update posted | Jan 2, 2024 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: